CHILDREN'S HOSPITAL CORPORATION, THE - TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES.
Key Details
Description
TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES.
Context & Analysis
On Nov 25, 2025, Department of Health and Human Services obligated $10,978,171.99 to CHILDREN'S HOSPITAL CORPORATION, THE for to identify novel adjuvant candidates that can be used to augment the efficacy of human vaccines.. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition with 12 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BOSTON, MA. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.
Market context
- Recompete outlook
- Ended Dec 29, 2025 (10 months ago). Recompete signal as of Oct 24, 2026: 33/100, combining time to the end date, the incumbent's history with this agency, whether the award was competed, and its size.
- Competition
- Competed, with 12 offers. 96% of 222 awards in this market (Department of Health and Human Services awards in NAICS 541714 over the last 3 years) were competed; median 1 offers.
- Award size
- At $11.0M, this award is larger than three in four of the 212 priced Department of Health and Human Services awards in NAICS 541714 over the last 3 years (median $1.2M).
- Incumbent at this agency
- CHILDREN'S HOSPITAL CORPORATION, THE has 2 other awards from Department of Health and Human Services, totalling $6.7M, 2023–2026.
- Largest vendors in this market
By obligations, Department of Health and Human Services awards in NAICS 541714 over the last 3 years.
- TECHNICAL RESOURCES INTERNATIONAL, INC. — 4 awards, $379.6M
- ALLUCENT GOVERNMENT SERVICES (US) LLC — 2 awards, $373.2M
- ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. — 4 awards, $342.2M
- PARATEK PHARMACEUTICALS, INC — 1 award, $265.3M
- GENENTECH INC — 1 award, $243.7M
Computed from USAspending award data on Oct 24, 2026.
Contractor Information
Related Opportunities
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE.BARDA - ASPR / DAAPPO / BARDA DCMA
BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE.BARDA - ASPR / DAAPPO / BARDA DCMA
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.